2025-03-17

Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance

2025-02-20

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results

2024-07-23

Triastek announces research collaboration and platform technology license agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics

2024-06-06

Triastek Awarded as 2024 Technology Pioneer by World Economic Forum

2024-04-25

Triastek Released Intellectual Property Strategy 2.0 On the 24th World Intellectual Property Day

2024-03-29

Triastek's 3D Printed Product for IgA Nephropathy, D23 (budesonide), Receives NMPA Clearance of IND Application